GLPwatch
Trials (2036)
Page 17 of 34.
- A Study of LY3305677 in Participants With Obesity Or Overweight
- Liraglutide In Overweight Patients With Type 1 Diabetes
- A Research Study to Compare Two Different Forms of Once-weekly Semaglutide in Two Different Injection Pens
- Efficacy and Mechanism of Exenatide on Improving Heart Function in Type 2 Diabetes With Heart Failure Patients
- Intravenous Exenatide in Coronary Intensive Care Unit (ICU) Patients
- Does the Hematopoietic Stem Cell Govern Residual Inflammatory Cardiovascular Risk in Type 2 Diabetes
- Effect of Gene Polymorphisms on GLP-1 Receptor Agonists Response in Patients With T2DM
- A Study of Bimagrumab Alone (LY3985863) and Bimagrumab With Tirzepatide (LY900042) in Healthy Participants
- Clinical Trial of Rybelsus (Semaglutide) Among Adults With Alcohol Use Disorder (AUD)
- LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
- New Onset Type 1 Diabetes: Role of Exenatide
- Saxenda: Underlying Mechanisms and Clinical Outcomes
- Remission Evaluation of a Metabolic Intervention for Type 2 Diabetes With IDegLira
- Liraglutide Treatment in Patients With Maturity-onset Diabetes of the Young (MODY)
- A Study to Investigate Weight Management With LY3841136 and Tirzepatide (LY3298176), Alone or in Combination, in Adult Participants With Obesity or Overweight With Type 2 Diabetes
- Evaluating the Impact of GLP-1 Receptor Agonists With Total Neoadjuvant Therapy in Rectal Cancer
- Exenatide for Treating Cocaine Use Disorder
- Effects of Exenatide on Hypothalamic Obesity
- Liraglutide in the Prevention of Type 2 Diabetes After Gestational Diabetes
- A Study of the Effect of (S)-Pindolol Benzoate (ACM-001.1) on Lean Body Mass (LBM) in Obese Patents During (PROACT 1), and Post-semaglutide Therapy (PROACT 2)
- A Study of Tirzepatide (LY3298176) in Chinese Participants With Type 2 Diabetes (SURPASS-CN-MONO)
- Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes
- A Study of Dulaglutide in Chinese Participants
- Efficacy and Safety of Semaglutide Injection Vs WEGOVY® in Chinese Obese Patients
- Clinical Trial for PB-119 in Subjects With Type 2 Diabetes Mellitus
- Simplification of Complex Insulin Regimens With Preserving Good Glycemic Control in Type 2 Diabetes
- Exendin PET/CT for Imaging of Paragangliomas
- Tirzepatide for Alcohol Use Disorder
- Sleeve Gastrectomy vs. Lifestyle & Medications: Impact on BMI Trajectory and Target Attainment in a Matched Cohort Study
- Type 1 Diabetes Impacts of Semaglutide on Cardiovascular Outcomes
- Comparative Effectiveness and Safety of Four Second Line Pharmacological Strategies in Type 2 Diabetes Study
- Efficacy of Liraglutide Therapy in Patients With IPAA
- HbA1c Variability in Type II Diabetes
- A Study of Tirzepatide (LY3298176) in Healthy Participants
- Investigating Bioequivalence Between Single-dose Liraglutide Administered Subcutaneously With Two Different Pen-injectors
- The Effects of Exenatide After Gastric Restriction
- Effect of Semaglutide on Cannabis Use in Adults With Cannabis Use Disorder
- Efficacy Evaluation of Different Medication Combination in Type 2 Diabetes Treatment
- Investigation of Safety, Tolerability and Pharmacokinetics of Multiple Doses of NNC0113-6856 in Healthy Participants, Including a Subset of Healthy Japanese Participants
- Lifestyle Counseling and Medication for Adolescent Weight Management
- A Study of LY3437943 in Chinese Participants With Obesity Or Overweight
- A Study to Assess the Effects of CT-868 Treatment on Glucose Homeostasis in Participants with Type 1 Diabetes
- Phase III Clinical Study Comparing the Efficacy and Safety of GZR18 Injection and Semaglutide (Wegovy®) in Adult Obese or Overweight Subjects
- Replication of the LEAD-2 Diabetes Trial in Healthcare Claims Data
- A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight
- Role of Semaglutide in Restoring Ovulation in Youth and Adults With Polycystic Ovary Syndrome
- Normal-weight Diabetes: Adipocyte-directed Therapy With Pioglitazone or Tirzepatide
- A Study of IBI362 in Subjects With HFpEF or HFmrEF Combined With Obesity
- Type II Diabetes Mellitus in Patients Exposed to Pravastatin and Paroxetine
- A Study of LY3437943 in Participants Who Have Obesity or Are Overweight
- Study to Examine the Effect on Glucose Control and Safety/Tolerability of Exenatide Given Two Times a Day to Subjects With Type 2 Diabetes
- Effects of GLP-1 Receptor Agonist on Fat Redistribution and Inflammatory Status
- Exenatide Plus Pioglitazone Versus Insulin in Poorly Controlled T2DM
- To Investigate the Blood Concentration of Liraglutide as Well as the Effects on Glucose and Insulin After 21 Days of Daily Subcutaneous Injections of Liraglutide or Placebo
- Effect of Liraglutide on Absorption of Paracetamol in Subjects With Type 2 Diabetes
- Study Examining Exenatide Long-Acting Release in Subjects With Type 2 Diabetes
- A Research Study to Compare Semaglutide to Insulin Aspart, When Taken Together With Metformin and Insulin Glargine, in People With Type 2 Diabetes
- Effect of LY2189265 on Insulin Secretion in Response to Intravenous Glucose
- GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Basal Insulin
- A Trial to Assess the Pharmacokinetics, Pharmacodynamics, and the Safety and Tolerability of Semaglutide in Healthy Male Japanese and Caucasian Subjects